Menopause Rx: The Heart of the Matter
The use of hormones during menopause was once thought to protect against heart disease, but that may not be the case.
FDA Approves Anti-Clotting Drug Savaysa
The U.S. Food and Drug Administration today approved the anti-clotting drug Savaysa (edoxaban tablets) to reduce the risk of stroke and dangerous blood clots (systemic embolism) in patients with atrial fibrillation that is not caused by a heart valve problem.
FDA Approves Rx for Bone Marrow Disease
The U.S. Food and Drug Administration today approved a new use for Jakafi (ruxolitinib) to treat patients with polycythemia vera, a chronic type of bone marrow disease. Jakafi is the first drug approved by the FDA for this condition.
Patients Have Power to Lower Post-Surgery Clot Risk
The risk for blood clots may go up after surgery, but patients can take steps to lower that risk.
FDA Approves Rx for Rare Type of Hemophilia
The US Food and Drug Administration (FDA) approved a new treatment Thursday for a rare form of hemophilia.
FDA Approves New Treatment for Rare Form of Hemophilia
The U.S. Food and Drug Administration yesterday approved Obizur [Antihemophilic Factor (Recombinant), Porcine Sequence] for the treatment of bleeding episodes in adults with acquired hemophilia A (acquired Factor VIII [FVII] deficiency).
Common Medicines May Increase Blood Clot Risk
When dealing with a headache or other pain, many people reach for over-the-counter pain relievers like naproxen or ibuprofen. But these types of medication, known as non-steroidal anti-inflammatory drugs (NSAIDS), could come with an increased risk of blood clots.
Aspirin Effective for Clot Prevention in Certain Patients
New research suggests that aspirin may be a safe alternative for those who have to stop taking anti-blood-clotting medicines.
Common Treatment for Pregnant Women May Be Ineffective
A common treatment for pregnant women prone to blood clots is a daily injection of blood thinner into the stomach. It's intended to prevent pregnancy complications, but recent research suggests this treatment may not work.
Reports Claim Drug Company Withheld Important Safety Information
The maker of a new anti-clotting medication may have withheld important safety information from regulators, according to several new reports.